Article Text

Download PDFPDF
A Retrospective Analysis of Neurolytic Celiac Plexus Block for Nonpancreatic Intra-Abdominal Cancer Pain
  1. David L. Brown, M.D.*
  1. From the Department of Anesthesiology, Virginia Mason Medical Center, Seattle, Washington
  2. *Chief of Anesthesiology


Neurolytic celiac plexus block (NCPB) has been reported to be an effective method for pain relief for a variety of intra-abdominal malignancies, especially pancreatic. In spite of this, few data exist concerning efficacy of the block for pain related to other intraabdominal tumors. The author analyzed the quality of pain relief obtained and complications during the use of NCPB in 66 patients with nonpancreatic intraabdominal malignancies. Seventy-three percent of the patients with nonpancreatic cancer pain had good pain relief, which in 59% of cases lasted through the remaining life of the patients. The incidence of neurologic injury (footdrop) was less than 0.5%. This therapy deserves more widespread use in patients with abdominal pain secondary to a variety of other malignancies, in addition to that of the pancreas.

  • Anesthetic technique
  • celiac plexus
  • Cancer, intraabdominal
  • Pain

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.